FRANCIA, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 3.504
EU - Europa 1.176
AS - Asia 378
AF - Africa 29
SA - Sud America 29
OC - Oceania 7
Totale 5.123
Nazione #
US - Stati Uniti d'America 3.483
IT - Italia 337
DE - Germania 232
IN - India 188
UA - Ucraina 177
SE - Svezia 128
CN - Cina 106
FI - Finlandia 96
IE - Irlanda 55
SG - Singapore 55
BG - Bulgaria 31
TG - Togo 28
AT - Austria 25
AR - Argentina 24
GB - Regno Unito 23
FR - Francia 21
RO - Romania 14
CA - Canada 13
BE - Belgio 10
NL - Olanda 9
HK - Hong Kong 8
MX - Messico 7
TR - Turchia 7
AU - Australia 6
RS - Serbia 5
RU - Federazione Russa 4
BR - Brasile 3
ES - Italia 3
IR - Iran 3
MY - Malesia 3
PK - Pakistan 3
JO - Giordania 2
PL - Polonia 2
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
LI - Liechtenstein 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 5.123
Città #
Fairfield 576
Woodbridge 292
Ashburn 249
Houston 239
Seattle 231
Chandler 224
Ann Arbor 201
Cambridge 199
Wilmington 183
Rome 131
Princeton 107
Plano 89
San Paolo di Civitate 82
Jacksonville 72
Lawrence 66
Beijing 64
Millbury 53
Boston 50
Dearborn 47
Dublin 42
San Diego 38
New York 32
Sofia 31
Andover 29
Singapore 29
Lomé 28
Norwalk 26
Federal 23
Vienna 20
Helsinki 17
Boardman 16
Fremont 14
Brussels 10
Falls Church 10
Bühl 9
Milan 8
Toronto 8
Des Moines 7
Hong Kong 6
Kunming 6
Phoenix 6
Pune 6
Hefei 5
Jinan 5
Marcq-en-baroeul 5
Munich 5
Amsterdam 4
Istanbul 4
Ottawa 4
San Mateo 4
Wuhan 4
Bergamo 3
Buffalo 3
Florence 3
Lahore 3
Lancenigo-Villorba 3
Lappeenranta 3
Los Angeles 3
Menlo Park 3
Naples 3
Brooklyn 2
Camparada 2
Cantalupo in Sabina 2
Catania 2
Central 2
Chengdu 2
Chongqing 2
Frankfurt am Main 2
Genoa 2
Hostalric 2
Indiana 2
Krakow 2
Las Vegas 2
Laurel 2
Leawood 2
Livorno 2
Mexico City 2
Nanchang 2
Ningbo 2
Pabillonis 2
Parma 2
Provo 2
Reggio Emilia 2
Rieti 2
Romainville 2
Siracusa 2
Sydney 2
São Paulo 2
Tehran 2
Torino 2
Tulln 2
Wandsworth 2
Washington 2
Adana 1
Ankara 1
Barcelona 1
Bari 1
Basking Ridge 1
Belize City 1
Bremen 1
Totale 3.716
Nome #
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists 112
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 100
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin 96
Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study 95
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort 94
Arrhythmia Detection in Single and Dual Chamber Implantable Cardioverter Defibrillators: The More Leads, the Better? 91
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 89
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 88
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 87
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 85
Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy 81
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 80
Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation 80
Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter-defibrillator 79
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 78
Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure 77
Anti-Aging Medicine: Molecular Basis for Endothelial Cell-Targeted Strategies - A Mini-Review 77
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 76
Oxidative stress and cardiovascular disease 75
p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. 73
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes 72
A novel electrocardiographic T-Wave measurement (Tp-Te Interval) as a predictor of heart abnormalities in hypertension: a new opportunity for first-line electrocardiographic evaluation 69
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators. 68
Left bundle branch block: pathophysiology, prognosis and clinical management 67
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis 67
Electrophysiological study and catheter ablation of a Mahaim fibre located at the mitral annulus-aorta junction 66
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool 66
Calcium Channel Blockers and Hypertension. 65
Deletion of p66shc gene protects against age-related endothelial dysfunction. 65
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 65
Vascular senescence at the crossroad between oxidative stress and nitric oxide pathways: Disclosing the secret of dorian gray 63
Clinical Course and Quality of Life in High-Risk Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators 63
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm 63
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 62
Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure 61
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man. 61
The apelin/APJ system. From vascular biology to heart failure 60
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 60
Circadian periodicity of the daily human heart rate variability chaos: further demonstration trough chronobiologic approach to the alpha exponent 59
The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress 59
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. 58
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator 57
Diabetes Mellitus and Metabolic Syndrome 56
Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. 56
Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure. is this enough? 56
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy. results from an Italian multicenter registry 56
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator 55
Idiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performance 54
Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition 52
Impact of hypertension on global cardiovascular risk stratification: analysis of a large cohort of outpatient population in Italy 52
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy 50
Analysis of the chaotic component of the sinusal R-R intervals as a tool for detecting a silent cardiac dysautonomia in type 2 diabetes mellitus 49
Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey. 49
Gene variants of calcium handling proteins as a determinant of ventricular arrhythmias in ICD recipients with heart failure 49
Diabetes Mellitus and Metabolic Syndrome 48
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 48
Nitric oxide release is impaired in hypertensives with familial history of stroke 47
Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies 46
Calcium Handling Proteins Common Gene Variants And Risk Of Ventricular Arrhythmias In ICD Recipients With Heart Failure. 46
Calcium handling proteins gene variants and the risk of ventricular arrhythmias in ICD recipients with heart failure: focus on extremely opposing phenotypes 46
Subcutaneous implantable cardioverter defibrillator implantation. An analysis of Italian clinical practice and its evolution 44
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure 42
Effect of gluten-free diet on cardiac performance in patients with idiopathic dilated cardiomyopathy and celiac disease . 42
Atrial fibrillation detection by multi-lead ECG processing at the edge 42
Repolarization abnormalities and arrhythmogenesis in hypertrophic myocardium 41
Extracellular matrix remodelling in myocardial hypertrophy and failure: focus on osteopontin 40
New oral anticoagulants in non-valvular atrial fibrillation. 39
Coeliac disease and dilated cardiomyopathy: a new association with potential therapeutic implications 38
L’ablazione della fibrillazione atriale come terapia di scelta? 37
Multi-modality imaging approach in a challenging case of surgically corrected partial anomalous pulmonary venous return and atrial tachycardia treated with radiofrequency ablation 36
Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique 36
Role of induced pluripotent stem cells in diagnostic cardiology 35
Il Trattamento dell’Insufficienza Cardiaca nelle Nuove Linee Guida ESC: dal 2005 al 2008, con Qualche Novità 34
Identification and Elimination of Ancillary Arrhythmias 33
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance. 32
Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy 32
La resincronizzazione cardiaca nelle classi NYHA I e II 31
Is a Reduced Entropy in Heart Rate Variability an Early Finding of Silent Cardiac Neurovegetative Dysautonomia in Type 2 Diabetes Mellitus? 29
Genetic deletion of the p66Shc adaptor protein protects against age-related cardiac arrhythmias. 29
Prevention of sudden cardiac death: focus on the subcutaneous implantable cardioverter-defibrillator 28
Cardiologia: lo stato dell'arte 27
[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use]. 27
DIZIONARIO DI MEDICINA TRECCANI 26
Pregnancy and heart rate variability in women affected by type1 diabetes mellitus with or without autonomic neuropathy. 26
ARITMIE 26
Is reduced entropy in hearth rate variability an early finding of silent cardiac neurovetative disautonomia in type 2 diabetes mellitus? 25
Rate o Rhythm Control? La Gestione della Fibrillazione Atriale nell’Insufficienza Cardiaca 25
Il Monitoraggio Continuo dell’Impedenza Intratoracica nella Gestione Ambulatoriale del Paziente con Insufficienza Cardiaca 25
L’associazione tra morbo celiaco e cardiomiopatia dilatativi idiopatica: effetti della dieta gluten –free 25
Viewpoint: Climbing the academic ladder in Italy. 24
The effects of gender on electrical therapies for the heart: procedural considerations, results and complications. A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC) 23
Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation 21
The loss of entropy circadian rhythm in sinusal R-R intervals of type 1 diabetic pregnant women suggests an indeterministic chaos in cardiac pacing (minimum delirium cordis syndrome). A newly identifiable type of silent cardiac dysautonomia? 20
Deficit di carnitina in pazienti affetti da morbo celiaco e cardiomiopatia dilatativa idiopatica:effetti della dieta priva di glutine 17
Prognostic implications of non-sustained VT morphology in high-risk patients with HCM 17
Variabilità della frequenza cardiaca (HRV) durante la gravidanza in donne affette da diabete mellito 1 con e senza neuropatia autonoma. 16
PREGNANCY AND HR VARIABILITY IN TYPE 1 DIABETIC WOMEN WITH OR WITHOUT AUTONOMIC NEUROPATHY. 16
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study 16
Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy 15
null 14
Totale 5.175
Categoria #
all - tutte 14.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019370 0 0 0 0 0 0 0 0 0 0 197 173
2019/20201.238 181 40 11 68 112 160 166 154 136 114 54 42
2020/2021440 52 63 12 23 9 32 5 35 50 88 54 17
2021/20221.040 15 68 96 57 142 23 22 104 91 74 168 180
2022/20231.066 178 203 31 91 110 92 22 65 128 29 49 68
2023/2024478 31 72 28 62 45 88 21 35 14 81 1 0
Totale 5.456